Search – Page 94 – Indianapolis Business Journal

Home » Search

Articles

Lilly, other drugmakers face federal pricing probe

November 9, 2015

Indianapolis-based Eli Lilly and Co. and other U.S. drugmakers are being investigated by federal prosecutors over their drug-pricing practices related to Medicare and Medicaid, according to newspaper reports.

Elements Financial bulks up with credit union merger

November 5, 2015

Indianapolis-based Elements Financial Federal Credit Union has scooped up 71-year-old State Service Credit Union, a move that provides Elements direct access to one of the largest employers in Indiana.

Lilly to build $70M R&D facility in Indy

November 2, 2015

The 130,000-square foot facility, set to open in 2017, will be a center for research work on so called small molecule drugs that can be turned into pills as opposed to large molecule or protein-based drugs that are typically injected.

UPDATE: Eli Lilly to build $70M R&D building in Indianapolis

November 2, 2015

The 130,000-square-foot building will be designed to encourage collaboration among scientists across different disciplines, which the company said is crucial to fostering innovation.

Merger chatter casts cloud over Dow AgroSciences

October 29, 2015

Talk of synergies and consolidation may warm the hearts of investors, who are eager for Midland, Michigan-based Dow Chemical to boost returns, but they cast uncertainty over some of central Indiana’s best scientific jobs.

2015 WOMAN OF INFLUENCE: Jenelle Smagala

October 29, 2015

Jenelle Smagala decided when she started the architectural firm Synthesis Inc. that she was going collaborate with engineers, contractors and others involved in the construction process, not just treat them as vendors.

Champions of 16 Tech see it as magnet for development, high-tech workers

October 29, 2015

City leaders want to make the 60-acre tract of land just north of the Indiana University School of Medicine campus a mix of all of the best the city has to offer and catch the eyes of more creative and highly sought-after workers.

Elanco president makes case for juiced-up cows in organic age

October 29, 2015

Jeff Simmons is on a counteroffensive as, increasingly, the drugs that Elanco makes—including antibiotics and productivity enhancers—have come under attack by food activists.

Media giant Pearson taps former Lilly CEO as chairman

October 26, 2015

Former Eli Lilly and Co. CEO Sidney Taurel has been named chairman of Pearson PLC, the London-based media and educational products giant announced Monday.

Lilly CEO: Drugmakers getting bum rap

October 26, 2015

Eli Lilly and Co. CEO John Lechleiter told Wall Street analysts recently that, while there have been “individual huge drug price increases,” the overall cost of drugs is rising very slowly and remains a small part of overall U.S. health care spending.

Mayoral foes: City must draw residents to bolster tax revenue

October 22, 2015

Attracting higher-wage residents is key to future growth as city revenues have stagnated and local governments have become increasingly reliant on income taxes. Republican Chuck Brewer and Democrat Joe Hogsett are proposing ways to bolster Indy neighborhoods.

LOPRESTI: Learn who’s stalking the sidelines with this NBA-coach trivia

October 22, 2015

Basketball bosses followed interesting paths to their high-profile profession.

Lilly predicts higher profits after better-than-expected quarter

October 22, 2015

Eli Lilly and Co. beat Wall Street’s expectations with its third-quarter profit, prompting the drugmaker to raise its full-year forecast by as much as 20 cents per share.

Pharmaceutical firms losing business to darknet drug deals

October 21, 2015

For the $300 billion pharmaceutical industry, the rapid growth of illegal underground marketplaces is a serious threat to profits and reputations.

Hogsett solidifies fundraising advantage over Brewer

October 16, 2015

Democrat Joe Hogsett bolstered his cash advantage in the Indianapolis mayoral race against Republican Chuck Brewer, reporting donations of more than $1.56 million in his most recent campaign finance filing.

Lilly competitor fails to win FDA backing for diabetes treatment

October 16, 2015

AstraZeneca Plc didn’t receive U.S. approval for a new diabetes treatment that combines two of its existing drugs. The combination would have competed with Glyxambi from Lilly.

Lines being drawn for Indiana’s next fight over LGBT rights

October 12, 2015

Months after a divisive religious freedom law thrust Indiana into an unwanted national spotlight, gay rights supporters and religious conservatives are preparing for another potentially bitter debate.

UPDATE: Lilly halts work on potential blockbuster cholesterol drug

October 12, 2015

Eli Lilly shares plunged nearly 10 percent Monday morning after it said it would stop development of evacetrapib, an experimental cholesterol drug with blockbuster potential.

Lilly expands China drug partnership in growing cancer market

October 12, 2015

Suzhou, China-based Innovent could receive payments totaling more than $1 billion if the cancer products it develops with Lilly reach certain milestones.

Eskenazi launches $50M effort to take brain care around the world

October 9, 2015

The safety-net hospital system in Indianapolis will create the Center for Brain Care Innovation and try to use telemedicine and a digital avatar to reach as many as 150,000 Hoosiers and 10 million patients outside Indiana by 2030.

« Previous 1 … 92 93 94 95 96 … 221 Next »

Search Results

4,410 results for '\"eli lilly\"'

Articles

Lilly, other drugmakers face federal pricing probe

Elements Financial bulks up with credit union merger

Lilly to build $70M R&D facility in Indy

UPDATE: Eli Lilly to build $70M R&D building in Indianapolis

Merger chatter casts cloud over Dow AgroSciences

2015 WOMAN OF INFLUENCE: Jenelle Smagala

Champions of 16 Tech see it as magnet for development, high-tech workers

Elanco president makes case for juiced-up cows in organic age

Media giant Pearson taps former Lilly CEO as chairman

Lilly CEO: Drugmakers getting bum rap

Mayoral foes: City must draw residents to bolster tax revenue

LOPRESTI: Learn who’s stalking the sidelines with this NBA-coach trivia

Lilly predicts higher profits after better-than-expected quarter

Pharmaceutical firms losing business to darknet drug deals

Hogsett solidifies fundraising advantage over Brewer

Lilly competitor fails to win FDA backing for diabetes treatment

Lines being drawn for Indiana’s next fight over LGBT rights

UPDATE: Lilly halts work on potential blockbuster cholesterol drug

Lilly expands China drug partnership in growing cancer market

Eskenazi launches $50M effort to take brain care around the world